Latest Us Expansion News

dorsaVi has inked a five-year sales agreement with Select Medical, opening access to over 1,900 US outpatient physical therapy centers for its FDA-approved motion analysis products. This follows a successful 18-month pilot validating clinical benefits in athlete rehabilitation.

Talga Group has signed a strategic cooperation agreement with United Catalyst Corporation, marking its entry into the US battery anode market and setting the stage for new graphite recycling and anode production facilities in South Carolina.

Cobram Estate Olives Limited has launched a $185 million capital raising to fund a major expansion of its vertically integrated olive oil operations in California, aiming to become the largest olive farmer in the US.

Cobram Estate Olives has secured $175 million through an institutional placement to accelerate its expansion in the US, aiming to increase its Californian olive groves to 3,600 hectares and boost olive oil production significantly by 2027.

The Calmer Co. reports a significant operational turnaround in H2 FY25, with sales momentum building through July and August, driven by cost reductions and new product launches in the US market.

archTIS Limited has opened the retail component of a $17 million entitlement offer to support its acquisition of Spirion LLC’s assets, aiming to expand its US footprint and enhance its cybersecurity product suite.

Pure Hydrogen Corporation has signed a Letter of Intent with California's GTS Group to supply hydrogen-powered heavy vehicles, marking a strategic push into the North American market.

Adherium Limited reported a $12.68 million net loss for FY2025 as it pivots towards commercialising its smart inhaler technology in the US, supported by a $4.49 million capital raise.

xReality Group (XRG) reports a landmark FY25 with 36% revenue growth driven by its Operator XR platform and a major US law enforcement contract. The company’s strategic shift towards immersive training technology signals robust momentum into FY26.

Echo IQ Limited reported a sharp increase in losses for FY25 despite revenue growth, while securing FDA clearance and expanding its AI-driven cardiology platform across major US networks.

BCAL Diagnostics has launched its first commercial breast cancer diagnostic test, BREASTESTplus™, in Australia, marking a key milestone despite a $7.24 million loss for FY2025. The company is also advancing its US operations with a new subsidiary and clinical trials underway.

Wiseway Group has delivered its strongest financial performance since listing, powered by a booming US division and a sharp focus on eCommerce imports across key markets.